ASND
Ascendis Pharma A/S
Latest News for ASND
By the end of this month, two pharmaceutical firms are set to receive a decision on their drug approval applications from the U.S. Food and Drug Ad......
In a report released on November 14, Derek Archila from Wells Fargo maintained a Buy rating on Ascendis Pharma, with a price target of $297.00. The......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND – Research Report) and Alkerme......
In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Ascendis Pharma, with a price target of $250.00. According ......
An announcement from Ascendis Pharma ( ($ASND) ) is now available. Ascendis Pharma reported strong financial results for the third quarter of 2025,......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $210.49 | +0.4% | 600.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |